|
|
Volumn 414, Issue 6860, 2001, Pages 159-160
|
|
An inflammatory drug prospect
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
AMYLOID BETA PROTEIN (1 42);
AMYLOID BETA-PROTEIN (1-42);
ASPARTIC PROTEINASE;
BACE1 PROTEIN, HUMAN;
BACE1 PROTEIN, MOUSE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PEPTIDE FRAGMENT;
PROTEINASE;
PROTEINASE INHIBITOR;
SECRETASE;
ACETYLSALICYLIC ACID;
AMYLOID PRECURSOR PROTEIN;
ANTIINFLAMMATORY AGENT;
CHELATING AGENT;
CLIOQUINOL;
ENZYME INHIBITOR;
HYDROXYCHLOROQUINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IBUPROFEN;
INDOMETACIN;
PREDNISONE;
SULINDAC SULFIDE;
VACCINE;
ALZHEIMER DISEASE;
AMINO ACID SEQUENCE;
ANIMAL;
HUMAN;
METABOLISM;
MOLECULAR GENETICS;
MOUSE;
NOTE;
ANTIINFLAMMATORY ACTIVITY;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG MECHANISM;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
VACCINATION;
ALZHEIMER DISEASE;
AMINO ACID SEQUENCE;
AMYLOID BETA-PROTEIN;
AMYLOID PRECURSOR PROTEIN SECRETASES;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ASPARTIC ENDOPEPTIDASES;
ENDOPEPTIDASES;
HUMANS;
MICE;
MOLECULAR SEQUENCE DATA;
PEPTIDE FRAGMENTS;
PROTEASE INHIBITORS;
DRUG DOSAGE;
INFLAMMATORY DISEASES;
DISEASES;
MEDICINE;
|
|
EID: 0035829817
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/35102656 Document Type: Letter |
|
Times cited : (31)
|
|
References (15)
|
